Literature DB >> 11550771

Acute gastric dilatation complicating the use of mydriatics in a preterm newborn.

S U Sarici1, M Yurdakök, S Unal.   

Abstract

A 2-month-old girl who had been born at 27-weeks' gestation was admitted for her screening examination for retinopathy of prematurity and given two drops each of cyclopentolate 0.5% and phenylephrine 2.5%. Approximately 2 h after completion of the examination, the infant had episodes of apnoea and vomiting. She was noted to be distended, and an abdominal radiograph demonstrated acute gastric dilatation. Apnoea, vomiting and distension resolved after 18 h and a repeat abdominal radiograph demonstrated resolution of the gastric dilatation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11550771     DOI: 10.1007/s002470100498

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  5 in total

1.  Acute gastric dilatation in a patient with spinal injury and multiple myeloma.

Authors:  Waheed Gul; Arif Qazi; Syed A Ali; Christopher Barde
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-06

2.  The local vasoconstriction of infant's skin following instillation of mydriatic eye drops.

Authors:  Atilla Alpay; Bahri Ermis; Silay C Ugurbas; Fatih Battal; Haci Murat Sagdik
Journal:  Eur J Clin Pharmacol       Date:  2010-09-11       Impact factor: 2.953

3.  Reported Adverse Drug Reactions in Infants: A Nationwide Analysis in Malaysia.

Authors:  Rosliana Rosli; Ahmad Fauzi Dali; Noorizan Abd Aziz; Long Chiau Ming; Mohamed Mansor Manan
Journal:  Front Pharmacol       Date:  2017-02-10       Impact factor: 5.810

4.  Systematic review of mydriatics used for screening of retinopathy in premature infants.

Authors:  Lisa Jean Kremer; David M Reith; Natalie Medlicott; Roland Broadbent
Journal:  BMJ Paediatr Open       Date:  2019-05-09

5.  Efficacy and safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening (MyMiROPS): study protocol for a non-inferiority crossover randomized controlled trial.

Authors:  Aikaterini K Seliniotaki; Anna-Bettina Haidich; Maria Lithoxopoulou; Helen Gika; Eleftheria Boutou; Christina Virgiliou; Martha Nikolaidou; Aristides Dokoumetzidis; Nikolaos Raikos; Elisavet Diamanti; Nikolaos Ziakas; Asimina Mataftsi
Journal:  Trials       Date:  2022-04-15       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.